Clinical Trial

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions

Study acronym: BIOMAG-III
Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to assess the safety and efficacy of the Freesolve resorbable magnesium scaffold (RMS) in the treatment of subjects with up to two de novo lesions in native coronary arteries compared to the Xience coronary drug-eluting stent (DES) system
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-20; most recent amendment 2026-07-23.
Status change: Not Yet Recruiting → Recruiting 2026-06-15
Trial Details
NCT Number NCT07258290
Lead Sponsor Teleflex
Conditions Coronary Disease, Heart Diseases, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Vascular Diseases, Chest Pain, Pain +7 more
Enrollment 1,859 participants
Start Date 2026-06-11
Primary Completion 2029-06 (estimated)
Study Completion 2033-06 (estimated)
Updated on ClinicalTrials.gov 2026-07-24